Saint Luke's Newsroom
Jan. 3, 2024

Kansas City Business Journal: Saint Luke's-BJC Merger Promotes Local Leaders to Executive Team
Saint Luke’s Health System and St. Louis’s BJC HealthCare officially merged, and three local leaders were added to the combined system’s leadership team.
Dec. 27, 2023

Healio: Top in Cardiology: Exercise Lowers Cardiac Arrest Risk, CV Benefits of Semaglutide
Dr. Mikhail Kosiborod reviewed research at the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease on the cardiovascular benefits of Ozempic/Wegovy for adults with obesity.
Dec. 25, 2023

FOX4: Saint Luke's East Patient Honors Nurses on Christmas Eve
One Saint Luke’s East patient took time on Christmas Eve to show appreciation for nurses and other health care workers who are spending the holidays at the hospital caring for others.
Dec. 25, 2023

KCTV: Local Man and Lee's Summit Mayor Honor Nurses on Christmas Eve
Not all professions get time off for the holidays, so one patient at Saint Luke’s East decided to do something about it.
Dec. 25, 2023

KSHB: Former Saint Luke's East Patient Pays It Forward to Nurses on Christmas Eve
Six months after a local man was a patient at Saint Luke's East Hospital, he is paying forward the kindness he was shown by the nursing staff.
Dec. 25, 2023

KMBC: Former Patient Decorates Saint Luke's East Hospital Courtyard to Thank Nurses
A former Saint Luke's East Hospital patient is showing his appreciation for nurses and other essential workers over the holidays.
Dec. 22, 2023

The Kansas City Beacon: COVID in Kansas City: Local Experts Answer Your Questions Going into the New Year

What do I do if I’m exposed? How can I stay safe while traveling? What’s the difference between COVID and the flu? Dr. Sarah Boyd, infectious disease physician at Saint Luke's Health System, answers.
Dec. 20, 2023

KMBC: KC-Led Clinical Trial on Popular Weight-Loss Drug Named Scientific 'Breakthrough of the Year'
The study revealed the popular weight loss drug semaglutide — commonly known as Ozempic and Wegovy — is highly effective at treating heart failure in patients with obesity.
Dec. 20, 2023

Kansas City Business Journal: Kansas City-Led Clinical Trial on Popular Weight-Loss Drug is Honored as a 'Breakthrough of the Year'
A groundbreaking study, led by Mikhail Kosiborod, MD, vice president of research at Saint Luke's Health System, has been named the scientific breakthrough of the year by Science Magazine.